Summary

United States Cardiovascular Devices Market is predicted to be priced at around US$ 25.60 Billion by 2030, according to Renub Research. Cardiovascular devices are essential in healthcare, comprising numerous clinical equipment crucial for diagnosing, treating, and coping with cardiovascular conditions. From pacemakers and stents to defibrillators and heart valves, those technologies notably improve affected person care, lessen hospitalizations, and enhance the quality of existence for those with cardiovascular problems. Their non-stop improvements underscore their essential position in modern healthcare, ensuring better consequences and advanced living standard requirements for people suffering from cardiovascular sicknesses.


United States Cardiovascular Devices Market is anticipated to undergo a CAGR of 6.32% during the forecast years (2024 to 2030)

The market is significantly increasing because of the upward push in cardiovascular sicknesses. As per the American Heart Association, cardiovascular disease (CVD) remains the main reason for death in the United States, with 928,741 casualties attributed to it. As cardiovascular situations remain a significant purpose of mortality and morbidity in the US, there may be a growing need for superior scientific devices to diagnose, treat, and manage those illnesses. The increasing prevalence of risk factors, including weight problems, high blood pressure, and diabetes, fuels the market's growth. Consequently, producers are investing in innovation and developing new cardiovascular devices to satisfy growing healthcare wishes, expanding the increase in the United States cardiovascular devices market.

Technology is pivotal in employing growth in the United States cardiovascular devices market. Advancements, including minimally invasive methods, superior imaging techniques, and innovative materials, enhance the efficacy and protection of cardiovascular interventions. Further, trends in wearable technology and remote monitoring structures permit higher control of cardiac conditions in outdoor traditional medical settings. These technological improvements enhance patient results, lessen healing times, and increase the efficiency of cardiovascular tactics, thereby stimulating the demand and fueling growth in the market. Hence, the United States cardiovascular devices market was US$ 16.67 Billion in 2023.

Numerous market players actively enforce strategic tasks, propelling an increase in the United States cardiovascular devices market. These initiatives involve research and improvement efforts to introduce progressive technologies, collaborations for collective know-how, and strategic partnerships to enhance market presence. By fostering non-stop improvements and increasing their product portfolios, those businesses contribute to the evolving panorama of cardiovascular care within the U.S. For instance, Myocardial Solutions, Inc. And United Imaging, Inc. have partnered strategically to open the cancer care and cardiology market for speedy cardiac magnetic resonance (M.R.) imaging. These proactive engagements reflect a commitment to addressing the growing occurrence of cardiovascular diseases and the U.S.'s rising need for superior clinical solutions.


In the United States cardiovascular devices market, diagnostics and monitoring devices have a significant presence

The United States cardiovascular device market is broken up by device type into Diagnostics and Monitoring Devices and Therapeutic and Surgical Devices. Diagnostic and monitoring devices are prominent in the United States cardiovascular devices market. This is because of their crucial role in sickness control and prevention. These devices allow healthcare professionals to diagnose cardiac situations, monitor patient health, and examine treatment effectiveness. With the prevalence of cardiovascular diseases at an upward push, the demand for reliable diagnostic tools keeps developing. From electrocardiography (ECG) machines to portable heart monitors, these devices empower early detection and proactive control of cardiovascular conditions, propelling their popularity in the cardiovascular device market in the United States.


Coronary artery disease is commonly treated in the United States cardiovascular device market

By application, the United States cardiovascular device market is categorized into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others. Coronary artery disease (CAD) is one of the conventional applications in the United States cardiovascular devices market due to its significant effect on public health. As a primary motive of heart-related morbidity and mortality, CAD necessitates a wide array of medical devices for analysis, treatment, and management. From stents and angioplasty balloons for revascularization to superior imaging technology like coronary angiography, the various devices cater to the complex desires of people living with CAD. The incidence of CAD underscores the continuing demand for revolutionary cardiovascular devices, solidifying its prominence in the market.


Utilization of diagnostic centers is among the highest in the cardiovascular devices market of the United States

By end-user, the United States cardiovascular device market is separated into Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Cardiac Catheterization Laboratories, and Others. Diagnostic facilities are one of the most used in the United States cardiovascular devices market. This is because of their pivotal role in cardiovascular fitness evaluation and control. These facilities house diverse diagnostic devices, including echocardiography machines, stress tests, and cardiac catheterization labs, allowing for comprehensive assessment and accurate analysis of cardiac conditions. With early detection and specific evaluation essential in cardiovascular care, diagnostic centers are important hubs for patient assessment, propelling their full-size usage in the market.


California is among the major players in the United States cardiovascular devices market

By states, the United States cardiovascular device market is divided into California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, and Rest of the United States. California is one of the distinguished players in the United States cardiovascular devices market. This is due to its robust healthcare surroundings and revolutionary panorama. Home to renowned research institutions, clinical facilities, and enterprise leaders, California fosters conducive surroundings for developing and commercializing modern cardiovascular technology. The state's vibrant biotechnology zone and strategic collaborations among academia and enterprise contribute to ongoing improvements in cardiovascular care, solidifying California's recognition as a vital hub in the cardiovascular devices market.


Key Players

The leading companies in the United States cardiovascular devices market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC, GE Healthcare, Johnson & Johnson Services, Inc., and Siemens Healthcare GmbH.


Device type – United States Cardiovascular Devices Market breakup in 2 viewpoints:

1. Diagnostic and Monitoring Devices
2. Therapeutic and Surgical Devices


Application – United States Cardiovascular Devices Market breakup in 4 viewpoints:

1. Coronary Artery Disease (CAD)
2. Cardiac Arrhythmia
3. Heart Failure
4. Others


End-User – United States Cardiovascular Devices Market breakup in 5 viewpoints:

1. Hospitals and Clinics
2. Ambulatory Surgical Centers
3. Diagnostic Centers
4. Cardiac Catheterization Laboratories
5. Others


States – United States Cardiovascular Devices Market of 29 States Covered in the Report:

1. California
2. Texas
3. New York
4. Florida
5. Illinois
6. Pennsylvania
7. Ohio
8. Georgia
9. New Jersey
10. Washington
11. North Carolina
12. Massachusetts
13. Virginia
14. Michigan
15. Maryland
16. Colorado
17. Tennessee
18. Indiana
19. Arizona
20. Minnesota
21. Wisconsin
22. Missouri
23. Connecticut
24. South Carolina
25. Oregon
26. Louisiana
27. Alabama
28. Kentucky
29. Rest of the United States


All the Key players have been covered from 3 Viewpoints:

• Overview
• Recent Development
• Revenue Analysis


Company Analysis:

1. Abbott Laboratories
2. Boston Scientific Corporation
3. Edwards Lifesciences
4. Cardinal Health Inc.
5. Medtronic PLC
6. GE Healthcare
7. Johnson & Johnson Services, Inc.
8. Siemens Healthcare GmbH.

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. United States Cardiovascular Devices Market

6. Market Share – United States Cardiovascular Devices Analysis

6.1 By Device Type
6.2 By Application
6.3 By End User
6.4 By States


7. Device Type – United States Cardiovascular Devices Market

7.1 Diagnostic and Monitoring Devices
7.2 Therapeutic and Surgical Devices


8. Application – United States Cardiovascular Devices Market

8.1 Coronary Artery Disease (CAD)
8.2 Cardiac Arrhythmia
8.3 Heart Failure
8.4 Others


9. End User – United States Cardiovascular Devices Market

9.1 Hospitals and Clinics
9.2 Ambulatory Surgical Centers
9.3 Diagnostic Centers
9.4 Cardiac Catheterization Laboratories
9.5 Others


10. States – United States Cardiovascular Devices Market

10.1 California
10.2 Texas
10.3 New York
10.4 Florida
10.5 Illinois
10.6 Pennsylvania
10.7 Ohio
10.8 Georgia
10.9 New Jersey
10.10 Washington
10.11 North Carolina
10.12 Massachusetts
10.13 Virginia
10.14 Michigan
10.15 Maryland
10.16 Colorado
10.17 Tennessee
10.18 Indiana
10.19 Arizona
10.20 Minnesota
10.21 Wisconsin
10.22 Missouri
10.23 Connecticut
10.24 South Carolina
10.25 Oregon
10.26 Louisiana
10.27 Alabama
10.28 Kentucky
10.29 Rest of the United States


11. Porter’s Five Forces Analysis – United States Cardiovascular Device Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – United States Cardiovascular Device Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players Analysis

13.1 Abbott Laboratories

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue Analysis

13.2 Boston Scientific Corporation

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue Analysis

13.3 Edwards Lifesciences

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue Analysis

13.4 Cardinal Health Inc.

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue Analysis

13.5 Medtronic PLC

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue Analysis

13.6 GE Healthcare

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue Analysis

13.7 Johnson & Johnson Services, Inc.

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue Analysis

13.8 Siemens Healthcare GmbH

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue Analysis

ページTOPに戻る

List of Tables/Graphs

Table-01: United States – Cardiovascular Devices Market Share by Device Type (Percent), 2019 – 2023
Table-02: United States – Forecast for Cardiovascular Devices Market Share by Device Type (Percent), 2024 – 2030
Table-03: United States – Cardiovascular Devices Market Share by Application (Percent), 2019 – 2023
Table-04: United States – Forecast for Cardiovascular Devices Market Share by Application (Percent), 2024 – 2030
Table-05: United States – Cardiovascular Devices Market Share by End User (Percent), 2019 – 2023
Table-06: United States – Forecast for Cardiovascular Devices Market Share by End User (Percent), 2024 – 2030
Table-07: United States – Cardiovascular Devices Market Share by States (Percent), 2019 – 2023
Table-08: United States – Forecast for Cardiovascular Devices Market Share by States (Percent), 2024 – 2030